|
|
| On Line Home Study Programs |
|
Impacting Morbidity & Mortality in Patients with COPD:
Optimal Use of Drug Therapy
Program Overview
This program will provide a summary of current literature and treatment options for patients with Chronic Obstructive Pulmonary Disease.
Presentation
The program can be completed by viewing the PowerPoint® slide show (using Microsoft® PowerPoint® 97 or later), answering the post-test questions and completing the program evaluation on line. Statements of credit can be printed after successful completion of the program.
Program Information
- Target Audience
All Registered Pharmacists.
This program is not accredited for Pharmacy Technicians.
- Learning Objectives
After participating in this program, the pharmacists should be able to:
- Interpret current guidelines and measures for effective management of chronic obstructive pulmonary disease (COPD)
- List drug therapies that have been shown to decrease exacerbations, hospitalizations, and overall mortality in patients with COPD
- Given a patient case, make recommendations for improvements in drug therapy that are likely to improve overall outcomes.
Program Faculty
- Faculty Disclosure Statement
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, Northeastern University Bouvé College of Health Sciences School of Pharmacy requires that faculty members disclose any relationship (e.g., shareholder, recipient of research grant, consultant, or member of an advisory committee) that the faculty may have with commercial companies whose products or services may be mentioned in their presentations. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on faculty presentations.
- Faculty and Disclosure Information
Jake Nichols, PharmD, MBA, BCPS
Director of Clinical Affairs
Commonwealth Medicine
UMass Medical School
- Speaker with honoraria: GlaxoSmithKline, Boehringer-Ingelheim
- Does not plan to discuss unlabeled/investigational uses of a commercial product.
Program Support
This program is supported by an educational grant from GlaxoSmithKline.
There is no fee for this program.
Continuing Education Accreditation Information
Northeastern University Bouvé College of Health Sciences School of Pharmacy is approved by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education. Pharmacists successfully participating in this program will receive a statement of credit for 1 contact hour (0.1 CEU). Statements of Credit may be printed on-line after successful completion of the learning assessment (70%).
ACPE # 027-000-07-075-H01-P. Initial release date: July 31, 2007, planned expiration date July 31, 2010.
Further Disclosure of Unlabeled Use and Disclaimer
|
|
|
